Figure S2 from Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer
Year: 2023
Type: other
Abstract: Glycolytic and PPP metabolites in HGSC cells compared to FT cells; increased expression of TCA cycle enzymes PDK1 and SUCLG2 do not decrease progression-free survival of HGSC patients. Related to Figure 1.
Authors: Erika S. Dahl, Raquel Buj, Kelly E. Leon, Jordan M. Newell, Yuka Imamura, Benjamin G. Bitler, Nathaniel W. Snyder, Katherine M. Aird
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362535995